Results 251 to 260 of about 359,344 (313)

Arrhythmia-Induced Cardiomyopathy in Atrial Fibrillation: Pathogenesis, Diagnosis, and Treatment. [PDF]

open access: yesLife (Basel)
Karakasis P   +8 more
europepmc   +1 more source

Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Atrial Fibrillation: Clinical Implications, Mechanisms, and Therapeutic Potential. [PDF]

open access: yesCureus
Ramadan MM   +14 more
europepmc   +1 more source

Arrhythmias, conduction disorders and sudden cardiac death in cancer patients and survivors: expert opinion of the working groups on cardio-oncology and on electrophysiology of the hellenic cardiac society. [PDF]

open access: yesCardiooncology
Keramida K   +10 more
europepmc   +1 more source

[Lidocaine as an anti-arrhythmia agent].

open access: yesTidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1969
openaire   +1 more source

[New anti-arrhythmia agents].

Zeitschrift fur Kardiologie, 1993
Use of class-I antiarrhythmic agents (encainide, flecainide or moricizine) to suppress asymptomatic ventricular premature depolarizations does not decrease, but rather increases mortality from cardiac events after myocardial infarction. These patients should not be treated with antiarrhythmic drugs until improved survival is shown in a controlled ...
P, Honerjäger, G, Schmidt
openaire   +1 more source

[Combined action of anti-arrhythmia agents].

Biulleten' eksperimental'noi biologii i meditsiny, 1991
A significant potentiation of antiarrhythmic effect was observed in 121 dogs with arrhythmias 24 and 48 hours after the coronary artery ligation when the following drugs were combined: N-propylajmaline bromide (1A class) and trimecaine (1B class), quinidine (1A class) and trimecaine, N-propylajmaline bromide and anaprilin (2 class). The potentiation is
E I, Gendenshteĭn   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy